Francesca Barone
Hoofd Techniek/Wetenschap/O&O bij CANDEL THERAPEUTICS, INC.
Vermogen: 200 424 $ op 30-04-2024
Actieve functies van Francesca Barone
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CANDEL THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2020 | - |
Loopbaan van Francesca Barone
Eerdere bekende functies van Francesca Barone
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-05-2019 | 01-11-2020 |
University of Birmingham | Corporate Officer/Principal | 01-01-2010 | 01-05-2019 |
Institute of Translational Medicine | Corporate Officer/Principal | - | - |
Opleiding van Francesca Barone
Sapienza University of Rome | Doctorate Degree |
King's College London | Doctorate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 4 |
Verenigde Staten | 3 |
Italië | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Doctorate Degree | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Consumer Services | 4 |
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CANDEL THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Institute of Translational Medicine |
- Beurs
- Insiders
- Francesca Barone
- Ervaring